Symmetrical and unsymmetrical analogues of isoxyl; active agents against Mycobacterium tuberculosis
Veemal Bhowruth1, Alistair K Brown, Robert C Reynolds
1School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Abstract:
Symmetrical and unsymmetrical analogues of the antimycobacterial agent isoxyl have been synthesized and tested against Mycobacterium tuberculosis H37Rv and Mycobacterium bovis BCG, some showing an increased bactericidal effect. In particular, compounds 1-(p-n-butylphenyl)-3-(4-propoxy-phenyl) thiourea (10) and 1-(p-n-butylphenyl)-3-(4-n-butoxy-phenyl) thiourea (11) showed an approximate 10-fold increase in in vitro potency compared to isoxyl, paralleled by increased inhibition of mycolic acid biosynthesis in M. bovis BCG. Interestingly, these isoxyl analogues showed relatively poor inhibition of oleate production, suggesting that the modifications have changed the spectrum of biological activity.
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Bacterial Phylum Actinobacteria
Antifungal Agents
Inhibitors of Gram-positive Cell Wall Synthesis
Tuberculosis


